Meridian Diagnostics/Gull
This article was originally published in The Gray Sheet
Executive Summary
Firms ink a definitive merger agreement under which Gull shareholders will receive $2.25 per share of common stock following Meridian's earlier rejection of a $3 per share deal ("The Gray Sheet" Aug. 31, In Brief). Gull will become a wholly-owned subsidiary of Meridian as a result of the deal